cis-trans-isomerization of [E]-5-(2-bromovinyl)-2,2'-anhydrouridine in vivo in rats.

1. [E]-5-(2-bromovinyl)-2,2'-anhydrouridine [( E]BVANUR) has considerable antiviral activity against herpes simplex virus type 1 (HSV-1). 2. [E]BVANUR is not a substrate of pyrimidine nucleoside phosphorylases, but it is an inhibitor of uridine phosphorylase (Ki = 450 nM). 3. [E]BVANUR (trans-isomer, parent compound) undergoes isomerization to [Z]BVANUR (cis-isomer), the only metabolite in rat, which was identified by h.p.l.c., mass spectra and n.m.r. spectroscopy. 4. Absorption of the drug from the gastrointestinal tract after oral administration is minimal. Absorption of [E]BVANUR from the abdominal cavity after i.p. administration was slow.

[1]  R. T. Walker,et al.  The synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine-related compounds , 1987 .

[2]  Z. Veres,et al.  Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine. , 1987, Drugs under experimental and clinical research.

[3]  K. Luk,et al.  Improvement of the bioavailability of the anti-herpes virus agent BVDU by use of 5'-O-alkoxycarbonyl derivatives with increased metabolic stability. , 1986, Journal of Antimicrobial Chemotherapy.

[4]  E. De Clercq,et al.  Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine. , 1986, Biochemical pharmacology.

[5]  Z. Veres,et al.  Enzymatic cleavage of 5-substituted-2'-deoxyuridines by pyrimidine nucleoside phosphorylases. , 1986, Biochemical pharmacology.

[6]  E. De Clercq,et al.  High-performance liquid chromatographic analysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine and its metabolites in serum, urine and herpes simplex virus type-1 infected cells. , 1986, Journal of chromatography.

[7]  T. Lin,et al.  Synthesis of 1-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-5-benzyluracil and its amino analogue, new potent uridine phosphorylase inhibitors with high water solubility. , 1985, Journal of medicinal chemistry.

[8]  Z. Veres,et al.  5-Substituted-2,2'-anhydrouridines, potent inhibitors of uridine phosphorylase. , 1985, Biochemical pharmacology.

[9]  T. Lin,et al.  Biological activity of two novel inhibitors of uridine phosphorylase. , 1985, Biochemical Pharmacology.

[10]  E. Clercq,et al.  Inhibition and reversal of the degradation of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo , 1985 .

[11]  N. Gerry,et al.  Simultaneous high-performance liquid chromatographic assay for 5-(2-bromo-E-ethenyl)-2'-deoxyuridine and its metabolite, 5-(2-bromo-E-ethenyl)uracil, in plasma. , 1985, Journal of chromatography.

[12]  E. Clercq.  Biochemical aspects of the selective antiherpes activity of nucleoside analogues , 1984 .

[13]  P. Calabresi,et al.  Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine. , 1984, Cancer research.

[14]  N. Gerry,et al.  Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridine. , 1984, Biomedical mass spectrometry.

[15]  E. De Clercq,et al.  Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo. , 1984, Nucleic acids research.

[16]  R. T. Walker,et al.  Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs. , 1984, Pharmacology & therapeutics.

[17]  E. De Clercq,et al.  Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets. , 1983, Biochemical pharmacology.

[18]  E. De Clercq,et al.  The relationship between incorporation of E-5-(2-Bromovinyl)-2'-deoxyuridine into herpes simplex virus type 1 DNA with virus infectivity and DNA integrity. , 1983, The Journal of biological chemistry.

[19]  B. Liermann,et al.  (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a good substrate for mammalian pyrimidine nucleoside phosphorylases. , 1983, Biomedica biochimica acta.

[20]  P. Wutzler,et al.  Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice. , 1982, Antiviral research.

[21]  E. De Clercq,et al.  Inhibitory effect of E-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on herpes simplex virus replication and DNA synthesis , 1982, Journal of Virology.

[22]  S. Chu,et al.  5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase. , 1982, Biochemical pharmacology.

[23]  E. Clercq.  Comparative efficacy of antiherpes drugs in different cell lines. , 1982 .

[24]  I. Gács,et al.  A new automatic combustion method for the liquid scintillation assay of tritium and carbon-14 in singly or doubly labelled organic materials , 1982 .

[25]  E. De Clercq,et al.  Incorporation of E-5-(2-halovinyl)-2'-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells. , 1982, The Journal of biological chemistry.

[26]  J. Sagi,et al.  (E)-5-(2-bromovinyl)-2'-deoxyuridine-5'-triphosphate as a DNA polymerase substrate. , 1981, Nucleic acids research.

[27]  S. Chu,et al.  Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase. , 1981, Biochemical pharmacology.

[28]  R. T. Walker,et al.  Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins. , 1981, Molecular pharmacology.

[29]  E. De Clercq,et al.  Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells. , 1981, The Journal of biological chemistry.

[30]  R. T. Walker,et al.  Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine. , 1981, Journal of Medicinal Chemistry.

[31]  E. De Clercq,et al.  On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. T. Walker,et al.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. , 1980, The Journal of infectious diseases.

[33]  R. T. Walker,et al.  Pharmacokinetics of E-5-(2-Bromovinyl)-2′-Deoxyuridine in Mice , 1979, Antimicrobial Agents and Chemotherapy.

[34]  R. T. Walker,et al.  (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. T. Walker,et al.  The synthesis and properties of some antiviral nucleosides , 1978 .

[36]  G. Kruppa,et al.  Unnatural nucleosides and nucleotides. III. Preparation of 2‐14C and 4‐14C labelled 5‐alkyluracils and 5‐alkyl‐2′‐deoxyuridines , 1978 .

[37]  P. Langen,et al.  Inhibition of thymidine phosphorylase by 6-aminothymine and derivatives of 6-aminouracil. , 1967, Biochemical pharmacology.

[38]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.